gastroenterology

News in brief: IBS doesn’t alter response to antibiotics in functional dyspepsia; Risk factor patterns for GERD and Barrett’s; Top ten Choosing Wisely for COVID-19

IBS doesn’t alter response to antibiotics in functional dyspepsia The presence of concomitant IBS does not significantly influence the improvement of functional dyspepsia symptoms after antibiotic therapy. A small Queensland study comprised 21 adults with functional dyspepsia, with or without IBS, managed with rifaximin (550 mg BD) for 10 days. The study found a significant ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic